VRXA
Veraxa Biotech
$0.98
−$0.02 (−2%)Oct 28, 2026
Key metrics
The numbers that frame VRXA today
- Market cap
- $138.58M
- Gross margin
- 66%
- ROIC
- -20.2%
- Div yield
- 0%
- 52wk Low
- $0.95
- 52wk High
- $27.36
Growth
Revenue and earnings trend for VRXA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VRXA
Is Veraxa Biotech a good buy?
No. Veraxa Biotech has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Veraxa Biotech is selling at a very high price.
What is the market capitalization of VRXA?
Veraxa Biotech's market capitalization is $138.58M.
What is the 52-week high for VRXA stock?
The 52-week high for Veraxa Biotech is $27.36. The current close of $0.98 is 96.4% below that high.
What is the 52-week low for VRXA stock?
The 52-week low for Veraxa Biotech is $0.95. The current close of $0.98 is 3.2% above that low.
Does VRXA stock pay dividends?
Veraxa Biotech does not currently show a dividend per share in the company data.